How long do new medicines take to reach Canadian patients after companies file a submission: A cohort study.

Published in: PloS one (2020)

Over 18% of the total time between when companies file for drug approval until the drug is available is due to decisions made by companies. Company decision times are shorter for drugs with expedited approvals compared to drugs with standard approvals.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
emergency department
patient reported outcomes
adverse drug
decision making